Concepedia

Armin Szegedi

AS

Statistics

Publications

91

Citations

5.8K

H-Index

45

Active since

1993

Affiliations

Johannes Gutenberg University Mainz(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Charité - Universitätsmedizin Berlin

Ludwig-Maximilians-Universität München

Allergan (United States)

Armin Szegedi is an author at Johannes Gutenberg University Mainz specializing in medicine, psychiatry, and psychopathology.

Top concepts

Publications per year

1993–2021

91

Publications

91

Ubrogepant for the Treatment of Migraine

David W. Dodick, Richard B. Lipton, Jessica Ailani et al. · New England Journal of Medicine · 2019 · 336 citations

Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine

Richard B. Lipton, David W. Dodick, Jessica Ailani et al. · JAMA · 2019 · 269 citations · Full text

Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial

Peter J. Goadsby, David W. Dodick, Jessica Ailani et al. · The Lancet Neurology · 2020 · 226 citations

, , +6

Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine

Armin Szegedi, Ralf Kohnen, Angelika Dienel et al. · BMJ · 2005 · 218 citations · Full text

What does the HAMD mean?

Stefan Leucht, Hein Fennema, Rolf R. Engel et al. · Journal of Affective Disorders · 2013 · 195 citations

1–5 of 91